1.Dasdo A Sinaga Cardiologist 2. SECONDARY PREVENTION PRIMARY PREVENTION: To prevent cardiovascular event in patients without evidence of cardiovascular disease RISK FACTORS…

1. Dr. Saurabh Gupta M.D. medicine 2.  Journal –NEJM  Pblished on march 29 2014 3. Evolocumab, a monoclonal antibody that inhibits proprotein convertase subtilisin/…

Sim ulta neo us t esti ng o f lip id p rofi le a nd gluc ose usi ng L ipid Pan el te st s trip s an d eGL U ™ ele ctro che mic al g luco se t est stri ps. Me asu res tot…

Slide 1 Lipoprotein management in Patients With Cardiometabolic Risk Consensus conference report JACC April 2008 Sandra Rodriguez, M.D. Internal Medicine Slide 2 Factors…

Slide 1 Teacher’s Survival Kit With former teachers … Joanette Coogan Katie Odom Professor Steve Chaney, PhD Slide 2 “I have come to believe that … a great teacher…

Slide 1 THE LIPID PANEL What are we missing? Robert St. Amant, MD, FAAFP Diplomate, American Board of Clinical Lipidology Baton Rouge General Medical Director, Lipid Center…

VITALIZER INTELLIGENT NUTRITION 1000 quality tests each time Vitalizer is made Whatâs In Vitalizerâ¢? Increase in HDL Decrease in total and non-HDL cholesterol Decrease…